Cannabis Bioscience International Holdings, Inc.
CBIH· OTC
CBIHCannabis Bioscience International Holdings, Inc.
Source filing unavailable
| Metric | Q1 2023 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | — | $17.29M | $21.19M |
| Net Income | -$212.03K | $3.10M | $3.98M |
| EPS Diluted | — | $0.24 | $0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cannabis Bioscience International Holdings, Inc. · CIK 1411057 · Engraved from SEC EDGAR
